<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11407</article-id><article-id pub-id-type="doi">10.7554/eLife.11407</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>The magnesium transporter A is activated by cardiolipin and is highly sensitive to free magnesium <italic>in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-42795"><name><surname>Subramani</surname><given-names>Saranya</given-names></name><aff><institution content-type="dept">Norwegian Centre of Molecular Medicine</institution>, <institution>Nordic EMBL Partnership University of Oslo</institution>, <addr-line><named-content content-type="city">Oslo</named-content></addr-line>, <country>Norway</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42794"><name><surname>Perdreau-Dahl</surname><given-names>Harmonie</given-names></name><aff><institution content-type="dept">Norwegian Centre of Molecular Medicine</institution>, <institution>Nordic EMBL Partnership University of Oslo</institution>, <addr-line><named-content content-type="city">Oslo</named-content></addr-line>, <country>Norway</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-35641"><name><surname>Morth</surname><given-names>Jens Preben</given-names></name><aff><institution content-type="dept">Norwegian Centre of Molecular Medicine</institution>, <institution>Nordic EMBL Partnership University of Oslo</institution>, <addr-line><named-content content-type="city">Oslo</named-content></addr-line>, <country>Norway</country><email>j.p.morth@ncmm.uio.no</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1098"><name><surname>Groisman</surname><given-names>Eduardo A</given-names></name><role>Reviewing editor</role><aff><institution>Yale University/HHMI</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>01</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e11407</elocation-id><supplementary-material><ext-link xlink:href="elife-11407-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>05</day><month>09</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>01</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Subramani et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Subramani et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The magnesium transporter A (MgtA) is a specialized P-type ATPase, believed to import Mg<sup>2+</sup> into the cytoplasm. In <italic>Salmonella typhimurium</italic> and <italic>Escherichia coli</italic>, the virulence determining two-component system PhoQ/PhoP regulates the transcription of <italic>mgtA</italic> gene by sensing Mg<sup>2+</sup> concentrations in the periplasm. However, the factors that affect MgtA function are not known. This study demonstrates, for the first time, that MgtA is highly dependent on anionic phospholipids and in particular, cardiolipin. Colocalization studies confirm that MgtA is found in the cardiolipin lipid rafts in the membrane. We further show that MgtA is highly sensitive to free Mg<sup>2+</sup> (Mg<sup>2+</sup><sub>free</sub>) levels in the solution. MgtA is activated when the Mg<sup>2+</sup><sub>free</sub> concentration is reduced below 10 μM and is strongly inhibited above 1 mM, indicating that Mg<sup>2+</sup><sub>free</sub> acts as product inhibitor. Combined, our findings conclude that MgtA may act as a sensor as well as a transporter of Mg<sup>2+</sup>.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>